METTL3 may play a carcinogenic part in OC cells through the AKT signalling pathway, and downregulation of METTL3 expression leads to reduced activation of the AKT signaling pathway in ovarian cancer cells [108]. Here, AKT1 is linked to ovarian carcinoma.